Refractory Plasma Cell Myeloma

specific

A multiple myeloma that is resistant to treatment.

42

Centers

5

Active Trials

Cancer Funding

Top Centers for Refractory Plasma Cell Myeloma(42)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.0
2
NCI Comprehensive
High-Volume Research Center
71.0
3
NCI Comprehensive
High-Volume Research Center
71.0
4
NCI Comprehensive
High-Volume Research Center
71.0
5
High-Volume Research Center
71.0
6
NCI Comprehensive
48.5
7
NCI Comprehensive
48.5
848.5
948.5
10
NCI Comprehensive
48.5
11
NCI Comprehensive
48.5
12
NCI Comprehensive
48.5
13
NCI Comprehensive
48.5
14
NCI Comprehensive
48.5
1548.5
16
NCI Comprehensive
48.5
1748.5
18
NCI Comprehensive
48.5
19
NCI Comprehensive
48.5
20
NCI Comprehensive
48.5
21
NCI Comprehensive
48.5
2248.5
23
NCI Comprehensive
48.5
2448.5
2548.5
2648.5
27
NCI Comprehensive
48.5
28
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
48.5
2948.5
3048.5
3148.5
32
NCI Comprehensive
48.5
3348.5
3448.5
3548.5
36
NCI Basic_laboratory
48.5
3748.5
3848.5
3948.5
4048.5
4148.5
4248.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →